Drug Type Therapeutic vaccine |
Synonyms Tergenpumatucel-L (USAN), HyperAcute Lung |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10429 | - | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Phase 3 | United States | 01 Feb 2013 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | United States | 01 Nov 2003 | |
Bronchiolo-Alveolar Adenocarcinoma | Phase 2 | United States | 01 Nov 2003 | |
Large Cell Carcinoma | Phase 2 | United States | 01 Nov 2003 | |
Non-small cell carcinoma | Phase 2 | United States | 01 Nov 2003 | |
Recurrent Non-Small Cell Lung Cancer | Phase 2 | United States | 01 Nov 2003 | |
Squamous Cell Carcinoma | Phase 2 | United States | 01 Nov 2003 | |
progressive non-small cell lung cancer | Phase 1 | United States | 01 Jan 2016 |